Height at diagnosis of malignancies

Area of Science:

• Pediatric Oncology
• Clinical Epidemiology
• Biostatistics

Background:

• Conflicting findings exist regarding the presenting height of children with malignancies, with some studies reporting taller patients and others reporting shorter ones.
• Potential reasons for these discrepancies include measurement bias, inadequate control populations, small sample sizes, subgroup analyses, and overreliance on simple significance tests.

Purpose of the Study:

• To clarify the relationship between presenting height and pediatric malignancies.
• To determine if children and adolescents diagnosed with specific cancers deviate from population height norms.

Main Methods:

• Analysis of height at diagnosis for 3657 children and adolescents (under 18 years).
• Inclusion of 10 malignancy types: acute lymphoblastic leukemia, non-Hodgkin's lymphoma, Hodgkin's disease, acute non-lymphoblastic leukemia, osteosarcoma, retinoblastoma, neuroblastoma, Wilms' tumor, rhabdomyosarcoma, and Ewing's sarcoma.
• Comparison of patient heights against published standards for control populations, with adjustment for multiple significance testing.

Main Results:

• No significant deviation from population height norms was observed in any of the 10 disease categories studied.
• Proper adjustment for multiple significance testing was applied to ensure robust findings.

Conclusions:

• This study indicates that children and adolescents diagnosed with common malignancies do not exhibit significant differences in height compared to their healthy peers.
• The findings help resolve inconsistencies in previous research on pediatric cancer patient stature.